Akero Therapeutics
Akero Therapeutics is an American biotechnology company that specializes in therapeutics for metabolic diseases, particularly known for its development of treatments targeting liver diseases such as MASH. The company has recently garnered attention following its acquisition by Novo Nordisk, which aims to expand its portfolio in metabolic medicine.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Denmark:
Novo Nordisk announced an agreement to acquire Akero Therapeutics, which works on treatments for metabolic diseases.
5
Denmark:
Novo announced that it had entered into an agreement to acquire the American biotech company Akero Therapeutics.
5